The regulatory region of the neuronal nicotinic acetylcholine (nACh) receptor α2 subunit gene is activated by the Brn-3b POU family transcription factor but not by the closely related factors Brn-3a and Brn-3c. This pattern of regulation has not previously been observed for other neuronally expressed genes, several of which, such as those encoding α-internexin or SNAP-25, are activated by Brn-3a and Brn-3c but repressed by Brn-3b. The α3 nACh receptor subunit gene is also shown to be activated by Brn-3a but is repressed by Brn-3b and Brn-3c. In contrast, the
INTRODUCTION
Nicotinic acetylcholine (nACh) receptors play a crucial role in signal transduction within the nervous system. A family of nACh receptor α and β subunits have been identified by molecular cloning techniques in the chick and rat [1, 2] . These various subunits show distinct patterns of expression within neuronal cells in developing and adult organisms [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Functional nACh receptors can be formed by complexes of α and β subunits or homomeric complexes of α7, α8 or α9 subunits [3, 12, 13] . The regulation of the expression of these subunits is controlled at the gene level by the actions of cellular transcription factors which modulate gene activity in both positive and negative directions.
The α2 nicotinic receptor subunit is one of the most restricted in its expression, being expressed in chickens for example only in the spiraformis lateralis nucleus of the diencephalon [14, 15] . Its expression appears to be under negative regulation by an inhibitor element that reduces the activity of the promoter itself and also has this effect when linked to the heterologous promoter of simian virus 40 (SV40) [16] . The regulatory region of the α2 subunit contains six copies of the sequence CCCCATGCAAT, which appears to be responsible for its inhibitory effect [16] . This sequence shows strong sequence similarity to the octamer consensus sequence ATGCAAAT which is bound by members of the POU family of transcription factors (for reviews see [17, 18] ). The three closely related members of the Brn-3 POU family Brn3a (also known as Brn-3 or Brn-3.0 ; [19] [20] [21] ), Brn-3b (also known as Brn-3.2 ; [20, [22] [23] [24] ) and Brn-3c (also known as Brn-3.1 ; [20, 21, 25] ) are specifically expressed in neuronal cells of the peripheral and central nervous systems with each factor having distinct but overlapping expression patterns [19] [20] [21] [23] [24] [25] . We have previously shown [26] that the Brn-3b factor activates a construct containing the α2 nACh receptor-regulating region linked to the SV40 promoter while Brn-3a and Brn-3c have no effect. The actions of the Brn-3 transcription factors on the α2
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Brn-3 POU family transcription factors have no effects on either the α7 or β4 nACh receptor subunit genes. The actions of Brn3b on the α2 subunit are thus in contrast to the inhibitory actions of Brn-3b on several promoters that are activated by Brn-3a. The different actions of the Brn-3 POU factors on the range of nACh receptor genes tested suggests that the novel stimulation of the α2 subunit by Brn-3b is specific to this subunit and not a general feature of nACh receptor genes.
subunit regulatory region contrast with their actions on other neuronal promoters such as those of the genes encoding SNAP-25 or α-internexin which are activated by Brn-3a and Brn-3c but repressed by Brn-3b [27] [28] [29] [30] . Thus the α2 nACh regulatory region is the first natural target for activation by Brn-3b to be described.
As the effects of the Brn-3 POU factor family on the α2 nACh receptor subunit regulatory region appear to be so unique, we wished to test the possibility that members of this family could regulate some of the other nACh receptor subunits to determine the nature of nACh receptor regulation by Brn-3. We have therefore investigated the effects of each of the forms of Brn-3 on the α2, α3, α7 and β4 nACh receptor subunit gene promoters.
MATERIALS AND METHODS

Plasmid DNA
The α2 receptor constructs were as described by Bessis et al. [16] . The α2.6-SV40-Sil construct contains the promoter region from k810 to j81 relative to the transcriptional start site upstream of the SV40 promoter and the luciferase gene. The α2.6-Sil construct contains the same promoter region upstream of the luciferase gene without any SV40 sequences.
The α3 receptor constructs were as described by Yang et al. [31] . The α3-238 construct contains the promoter region from k238 to j47 relative to the α3 transcriptional start site upstream of the luciferase gene. The α3-1607 construct contains the promoter region from k1607 to j47 upstream of the luciferase gene.
The α7 receptor constructs were as described by MatterSadzinski et al. [32] . The NR, NP and NSa constructs contain respectively the promoter regions from k1383 to k188, k406 to k188 and k230 to k188 respectively, upstream of the α7 initiator ATG inserted immediately upstream of the chloramphenicol acetyltransferase (CAT) gene.
The β4 receptor construct was as described by Hu et al. [33] and contains the region from k89 to j137 relative to rat β4 transcription initiation site upstream of the luciferase gene.
The Brn-3a, Brn-3b and Brn-3c expression vectors contain full-length cDNA clones for each of these proteins [20] cloned under the control of the Moloney murine leukaemia virus promoter in the vector pLTRpoly, which has been modified by deletion of a cryptic splice site in the SV40 3h untranslated region [20, 27, 28] . In the case of Brn-3a an expression vector containing cDNA derived from the spliced form of the Brn-3a mRNA was used. The Brn-3b vector contains a full-length cDNA derived from the intronless RNA which encodes Brn-3b, while the Brn3c vector similarly contains a full-length cDNA derived from the mRNA encoding Brn-3c which is produced from the primary transcript by the removal of a single intron [20] . Brn-3 chimeras contained PCR-generated sequences encoding the subdomains of Brn-3a and Brn-3b cloned into the same vector [20] . The subdomains of Brn-3a and Brn-3b were as follows, Brn-3a : subdomain I, amino acids (aa) 1 to 40 ; subdomain II, aa 41 to 108 ; subdomain III, aa 109 to 267 ; subdomain IV (POU domain), aa 268 to the end. Brn-3b : subdomain II, aa 1 to 92 ; subdomain III, aa 93 to 169 ; subdomain IV (POU domain), aa 170 to the end. Chimeric construct 1 contained subdomains I, II and III from Brn-3a plus subdomain IV from Brn-3b ; chimeric construct 2 contained subdomains I, II and IV from Brn-3a plus subdomain III from Brn-3b ; chimeric construct 3 contained subdomains I and II from Brn-3a plus subdomains III and IV from Brn-3b ; chimeric construct 4 contained subdomain IV from Brn-3a plus subdomains II and III from Brn-3b.
Transfection
Transfection of DNA was carried out according to the method of Gorman [34] . Routinely 1i10' BHK-21 cells [35] were transfected with 10 µg of the reporter plasmid and 10 µg of the expression vector. In all cases cells were harvested 72 h later. The amount of DNA taken up by the cells in each case was measured by slot blotting the extract and hybridization with a probe derived from the ampicillin resistance gene in the plasmid vector [36] . This value was then used to normalize the values obtained in the luciferase or CAT assay as a control for differences in uptake of plasmid DNA in each sample.
Luciferase and CAT assays
Assays of luciferase activity were carried out using a commercially available kit (Promega) and a Turner luminometer with extracts which had been equalized for protein content according to the method of Smith et al. [37] . Assays of CAT activity were carried out according to the method of Gorman [34] using samples which had been equalized for protein content according to the method of Smith et al. [37] .
RESULTS
In previous studies we transfected BHK-21 fibroblasts cells [36] which lack any endogenous Brn-3 [22] with plasmids expressing each of the forms of Brn-3 [20] and a reporter plasmid containing the entire α2 gene inhibitory region (α2.6) upstream of the SV40 promoter driving the luciferase gene [26] . This construct was strongly activated by Brn-3b and unaffected by Brn-3a and Brn3c. As the construct used in these studies contained the α2 regulatory region from k810 to j81 relative to the transcriptional start site cloned upstream of the SV40 promoter, we wished to test whether the effects we observed could also be obtained in the absence of any SV40 sequences. In the present study we therefore compared the effects of Brn-3 forms on the α2.6 construct containing the k810 to j81 region with and without the SV40 promoter (Table 1) . Both reporter gene constructs were strongly transactivated by co-transfection with the Brn-3b expression vector compared with the level of promoter activity when co-transfected with the expression vector lacking any insert. In contrast neither the Brn-3a or Brn-3c constructs had any effect on the activity of either α2.6 construct. Hence Brn3b can activate the α2 nACh receptor promoter in the absence of any SV40 sequences.
To investigate whether the effects were specific to the α2 nACh receptor promoter we used a construct containing the region from k1607 to j47 relative to the transcriptional start site of the α3 nACh receptor promoter linked to the luciferase gene. When BHK-21 fibroblasts were co-transfected with this construct and plasmids expressing each of the forms of Brn-3 the α3 (1607) construct was transactivated by Brn-3a and repressed by Brn-3b and Brn-3c (Table 2 ). In the case of the α2 promoter transactivation by Brn-3b is lost when the regulatory region containing six copies of the CCCATGCAAT motif is truncated [26] . In contrast, in the case of the α3, similar strong activation by Brn3a and mild repression by Brn-3b and Brn-3c were also observed for a truncated α3 promoter construct containing the region of the promoter from k238 to j47 (Table 2 ). In other promoters activated by Brn-3a and repressed by Brn-3b, Brn-3b can also interfere with activation by Brn-3a [27] [28] [29] . This was not so in the case of the α3 promoter, however, since transactivation of each construct by Brn-3a was unaffected by co-transfection with either Brn-3b or Brn-3c (Table 3 ). In previous experiments using chimeric constructs containing different regions of Brn-3a and Brn-3b we have shown that different regions are required for activation depending on the target promoter involved (Figure 1 ). In view of the apparent difference between Brn-3a activation of the α3 promoter compared with other neuronal promoters we examined the effects of these chimeric constructs and the isolated POU domains of Brn-3a and Brn-3b on the α3 promoter. In these experiments the α3 promoter was activated by Brn-3a and chimeric construct 4 ( Table 4 ), suggesting that subregions II and III must come from the same Brn-3 form and be combined with a Brn-3a POU domain (subregion IV) for activation of this promoter.
To test whether Brn-3a or Brn-3b could activate other nACh receptor gene promoters we used constructs either containing the region of the α7 promoter from k1383 (NR), k406 (NP) or k230 (NSa) to k188 relative to the translational start site [32] or the region of β4 from k89 to j137 relative to the transcriptional start site [33] . When BHK-21 fibroblasts were cotransfected with either the α7 (NR), α7 (NP) or α7 (NSa)
Figure 1 Summary of gene transactivation data with the Brn-3a (A) and Brn-3b (B) vectors and chimeric proteins containing different subregions of each factor
Data are summarized for constructs containing a consensus octamer motif cloned upstream of a test thymidine kinase promoter [27] , the α-internexin promoter [29] , the α2 promoter [26] and the α3 promoter (Table 4 , this paper). The division of Brn-3a and Brn-3b subdomains I, II, III and IV is as follows, Brn-3a : subdomain I, amino acids (aa) 1 to 40 ; subdomain II, aa 41 to 108 ; subdomain III, aa 109 to 267 ; subdomain IV (POU domain), aa 268 to the end. Brn-3b : subdomain II, aa 1 to 92 ; subdomain III, aa 93 to 169 ; subdomain IV (POU domain), aa 170 to the end. construct and plasmids expressing each of the forms of Brn-3, all three α7 constructs were unaffected by Brn-3a, Brn-3b or Brn-3c (Table 5) . Similarly, when BHK-21 fibroblasts were co-transfected with the β4 construct and plasmids expressing each of the forms of Brn-3 all three Brn-3 forms (Brn-3a, Brn-3b and Brn-3c) failed to affect the basal expression of the β4 construct (Table 6 ).
DISCUSSION
The activation of the neuronal nACh receptor α2 region by Brn3b reported here demonstrates that our previous reports of such activation [26] are independent of the presence of an SV40 promoter within the construct and is due to a direct action of Brn-3b on the α2 promoter. Such activation of this nACh promoter by Brn-3b thus far appears to be unique since the promoters of several other neuronally expressed genes such as α-internexin [29] or SNAP-25 [30] have been shown to be activated by Brn-3a, but repressed by Brn-3b. The present studies also 9.09p1.89* demonstrate that such activation by Brn-3b is not a general feature of its actions on nACh receptor subunits. Thus α3 nACh receptor reporter constructs were activated by Brn-3a but not Brn-3b and Brn-3c, whereas the α7 and β4 subunits were unaffected by any of the factors. These results demonstrate that different nACh receptor subunits show regulation by the Brn-3 family POU factors but suggest that these POU factors do not control all nACh receptor subunit expression. The activation of the α2 nACh receptor promoter by Brn-3b depends on the intactness of the regulatory region from k144 to j81 containing six copies of the motif CCCCATGCAAT. Truncation of this regulatory region so that one, two or four copies of the motif are present results in loss of Brn-3b activation, although these truncated constructs, unlike the full-length construct, are activated by Brn-3c [26] . In contrast similar activation by Brn-3a and repression by Brn-3b and Brn-3c was observed when the α3 construct was truncated from k1607 to k238.
The full-length α3 nACh receptor has previously been shown to be strongly activated by the POU domain factor SCIP\Tst-1 [31] . The POU domain factors Oct-2 and Brn-4 were also shown to weakly activate this promoter although Oct-1 had no effect [31] . The minimal promoter region from k238 is also activated by SCIP\Tst-1 but lacks upstream SCIP\Tst-1-binding sites [31] . Moreover, mutants of SCIP\Tst-1 which cannot bind to DNA still activate the α3 promoter [31] and it has therefore been suggested that SCIP\Tst-1 activates this promoter by proteinprotein interactions with other transcription factors rather than by direct DNA binding. The lack of obvious octamer or octamerrelated motifs in the k238 to j47 region of the α3 promoter might suggest that Brn-3a activates the α3 promoter by a similar mechanism not involving DNA binding. This would explain some of the differences in α3 promoter activation from that observed for example on a test promoter containing Brn-3a-binding sites [27, 28] or on the α-internexin gene promoter [29] which contains Brn-3a-binding sites [38] . Thus unlike the α3 promoter these promoters are also activated by Brn-3c and activation by Brn-3a can be inhibited by Brn-3b, whereas this is not the case on the α3 promoter. The results obtained for activation of the α3 promoter by Brn-3a and the chimeric construct 4 might suggest that if activation is occurring via this mechanism the protein-protein interactions require subregions II and III from the same Brn-3 form combined with a POU domain (subregion IV) from Brn-3a. This contrasts with the thymidine kinase promoter with an added octamer motif (tKoct) which was activated by all constructs containing a Brn-3a POU domain [27] , and the α-internexin promoter which was activated by constructs containing a Brn-3a-derived N-terminus [29] . The strong activation of the α3 promoter by SCIP\Tst-1 was cell-type-dependent [31] and much reduced in non-neuronal cells. In our study we have used the BHK-21 cell line and the relatively small activation by Brn-3a may thus be a consequence of the use of a non-neuronal cell type.
Alternatively it is possible that the α3 promoter from k238 to j47 does contain binding sites for Brn-3a. Thus several different consensus binding sites for the factor have been reported by different groups [39, 40] . Moreover, in the α-internexin promoter removal of all the octamer-like motifs which can bind Brn-3a to yield a promoter containing only the region downstream of k77 did not abolish the ability of the promoter to respond to Brn-3a [29] . However, further truncation to k46 rendered the promoter non-responsive to Brn-3a and a novel binding site for Brn-3a was subsequently detected in the region from k77 to k46 [38] .
Whatever the precise mechanism by which Brn-3a activates the α3 promoter, it is clear that this promoter is one of several neuronal promoters activated by this factor. In contrast, the activation of the α2 promoter by Brn-3b is thus far unique. The α2 nACh receptor subunit is the most restricted in its distribution and clearly the ability of Brn-3b to activate its promoter may play a role in its limited expression within the nervous system. The α3 subunit is more widely distributed and activation by Brn3a, together with suppression by Brn-3b and Brn-3c, could play a role in its expression within the nervous system. Thus in situ hybridization studies comparing the distribution of the various forms of Brn-3 with that of the α2 and α3 subunits will be necessary to investigate this further. The α7 promoter is activated during development [32] ; however, the Brn-3 POU factors do not appear to affect its expression. Similarly the Brn-3 factors do not modulate the activity of the β4 promoter even though the α3 and β4 subunit genes are on the same chromosome and are closely linked [31] , suggesting that they could be subject to similar regulation.
In conclusion the Brn-3 POU family transcription factors are able to regulate the α2 and α3 nACh receptor subunit gene expression but not the α7 and β4 subunits. The α2 subunit is activated by Brn-3b while the α3 subunit is repressed by this Brn-3 form but activated by Brn-3a. This indicates that the action of Brn-3 transcription factors on nACh receptor gene expression is dependent on the individual characteristics of each subunit promoter.
